Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors

LOS ANGELES, March 27, 2023 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced the…

About the Author

has written 39381 stories on this site.

Copyright © 2010 Business and Corporate News.